Reply to Volkman et al. Comment on "Fust et al. The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan.

Michele Kohli, Keya Joshi, Ekkehard Beck, Yuriko Hagiwara, Nicolas Van de Velde, Ataru Igarashi

Abstract read

In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michele KohliQuadrant Health Economics Inc., 92 Cottonwood Crescent, Cambridge, ON N1T 2J1, Canada.ORCID 0000-0002-6032-9356

Keya JoshiModerna, Inc., 325 Binney Street, Cambridge, MA 02142, USA.

Ekkehard BeckModerna, Inc., 325 Binney Street, Cambridge, MA 02142, USA.ORCID 0000-0002-2022-9190

Yuriko HagiwaraModerna, Inc., 4-1-1 Toranomon, Kamiyacho, Minato Ward, Tokyo 105-6923, Japan.ORCID 0000-0002-3754-8278

Nicolas Van de VeldeModerna, Inc., 325 Binney Street, Cambridge, MA 02142, USA.

Ataru IgarashiGraduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In their comment [...].

Indexed as

coronaviruscost-effectivenessCOVID-19JapanSARS-CoV-2vaccination

Identifiers

PMID39460341

DOI10.3390/vaccines12101175

PMCPMC11511137

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.